Work

Age serves as the silent architect of FIB-4’s precision in unveiling advanced hepatic fibrosis in MASLD with T2DM: Correspondence to letter to the editor on “Diagnostic accuracy of the fibrosis-4 index for advanced liver fibrosis in nonalcoholic fatty liver disease with type 2 diabetes: a systematic review and meta-analysis”

Year: 2024

Type: letter

Abstract: development and progression of metabolic dysfunction-associated steatotic liver disease (MASLD).The co-incidence rate of T2DM and MASLD is very high across all regions globally.3 All MASLD are candidates for hepatic fibrosis evaluation, and those with coexisting T2DM

Source: Clinical and Molecular Hepatology

DOI: 10.3350/cmh.2024.1160

Authors: Ji Won Han, Dae Won Jun

Institutions: The Catholic University of Korea Seoul St. Mary's Hospital, Catholic University of Korea, Hanyang University Seoul Hospital, Hanyang University

Language: English

Topic: Liver Disease Diagnosis and Treatment

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $32